Resources
Menu
Close
Resources
Contact us
Oral solid dose
Sterile injectables
Antibody-drug conjugates
Tech transfer
OSD manufacturing
SI manufacturing
ADC manufacturing
Careers
Leadership team
Sustainability
IP protection
Expert insights
What does it take to navigate the future of OSD development?
The oral solid dosage (OSD) market is rapidly evolving. As the demand for OSD products rises, developers and manufacturers are under pressure to adopt proactive and innovative approaches, embracing strategies that make OSD production:
Smarter: Leveraging advanced technologies and data-driven insights to optimize formulations, streamline processes and enhance product quality.
Faster: Implementing strategies to accelerate OSD development and manufacturing without compromising quality or safety.
More patient-centric: Prioritizing patient needs and preferences throughout OSD development.
In our latest eBook, we explore the key trends shaping the future of OSD and provide insights into how to optimize your OSD development and manufacturing processes to prepare for future demands.
Please submit the form below to download your resource
Pfizer CentreOne would like to send you information which we believe may be of value to you and relevant to your work. If you would like to receive such information, please click below.
By clicking here and clicking “Submit” below, I consent to receiving thought leadership, industry news, and invitations by email or other electronic means, which Pfizer CentreOne believes may be of value to me, relevant to my work and tailored to my professional profile and interests. This may include promotional information on products, services and events provided or organized by Pfizer CentreOne.
By clicking the "Submit” button, you confirm that the information you have provided above is correct, and you agree to Pfizer’s processing of your personal data, including its transfer internationally and to third parties, in accordance with the Pfizer Privacy Policy and Pfizer website terms of use.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Submit
Success
Thank you, your submission has been received!
Success
Thank you, your submission has been received!
Latest marketing updates
Let’s stay in touch
Pfizer CentreOne would like to send you information which we believe may be of value to you and relevant to your work. If you would like to receive such information, please tick the box below.
BY TICKING THE BOX AND CLICKING “LET’S COLLABORATE” BELOW, I CONSENT TO RECEIVING THOUGHT LEADERSHIP, INDUSTRY NEWS, AND INVITATIONS BY EMAIL OR OTHER ELECTRONIC MEANS, WHICH PFIZER CENTREONE BELIEVES MAY BE OF VALUE TO ME, RELEVANT TO MY WORK AND TAILORED TO MY PROFESSIONAL PROFILE AND INTERESTS. THIS MAY INCLUDE PROMOTIONAL INFORMATION ON PRODUCTS, SERVICES AND EVENTS PROVIDED OR ORGANIZED BY PFIZER CENTREONE.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Let's Collaborate
A CMO for therapies that define legacies
Follow us
Latest marketing updates
Sign up
© 2025 Pfizer Inc. All rights reserved. Pfizer CentreOne is a registered trademark of Pfizer Inc. Privacy Policy | Terms of Use